ROCKVILLE, Md.--(BUSINESS WIRE)--Celera Group (NYSE:CRA), an Applera Corporation business, today reported a net loss of $4.5 million, or $0.06 per share, for the third quarter of fiscal 2007, compared to a net loss of $23.3 million, or $0.31 per share, for the third quarter of fiscal 2006. The third quarter fiscal 2007 results included a tax benefit of approximately $0.4 million for R&D credits. The third quarter fiscal 2006 results included a $20.9 million pre-tax charge for restructuring costs associated with the decision to exit small molecule drug discovery and development and the integration of Celera Diagnostics into Celera. The third quarter fiscal 2006 results also included a $3.1 million pre-tax gain from the sale of an investment. All per share amounts refer to Applera Corporation-Celera Group Common Stock.
